ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

ASTRO Members Approve Governance, Dues Changes

January 17, 2003

Spiegelman Selected For BMS Award; Einstein Cancer Center Wins Grant.

July 4, 2003

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992